Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Nodal pCR and overall survival following neoadjuvant chemotherapy for node positive ER+/Her2- breast cancer

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-07152-2Source: DataRank Database

Nodal pCR and overall survival following neoadjuvant chemotherapy for node positive ER+/Her2- breast cancer is a research paper published in Breast Cancer Research and Treatment (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.24)OA: greenTopics (38)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Tanya L. Hoskin ORCID,Courtney N. Day ORCID,Amy K. Schulze,Matthew P. Goetz ORCID,Judy C. Boughey ORCID

Live enrichment

PubMed:37878154 PMC:PMC11385785 OpenAlex:https://openalex.org/W4387931028

Mayo Clinic Breast Cancer Specialized Program of Research Excellence Grant, National Institutes of Health

Grant: P50CA 116201

George M. Eisenberg Foundation for Charities

Grant: George M. Eisenberg Foundation for Charities

National Institutes of Health

Grant: 5P50CA116201-08

Career Development (Ingle)

FWCI

1.24

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

greenLicense: Springer Nature TDM

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11385785/pdf/nihms-2003814.pdf

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11385785

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11385785/pdf/nihms-2003814.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s10549-023-07152-2.pdf

publisherhttps://link.springer.com/article/10.1007/s10549-023-07152-2/fulltext.html

Fields of Study

Breast Cancer Treatment StudiesBreast Lesions and CarcinomasMedical Imaging Techniques and ApplicationsMedicine03 medical and health sciences0302 clinical medicine

MeSH Terms

Antineoplastic Combined Chemotherapy ProtocolsBreastBreast NeoplasmsFemaleHumansPrognosisChemotherapy, AdjuvantErb-b2 Receptor Tyrosine KinasesReceptor, ErbB-2Ki-67 AntigenNeoadjuvant Therapy

Keywords

Breast cancerOncologyMedicineNODALChemotherapyInternal medicineNeoadjuvant therapyCancerSurvivalKi67Neoadjuvant chemotherapyNodal PcrKi-67 AntigenChemotherapy, AdjuvantAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleBreast NeoplasmsBreastPrognosisErb-b2 Receptor Tyrosine Kinases

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being